EnGraft Technologies
Marina Del Rey, US · Founded 2023 · Delaware corporation
Engraft Technologies develops surgical instruments for hair transplant surgery, including the Duplex Implanter, aimed at improving the safety, consistency, and efficiency of the procedure for practitioners. The company operates in the medical device and hair restoration field.
Founders & leadership
EnGraft Technologies was founded in 2023 by Dr. Pascal Boudjema and Dr. William Rassman.
DP
Dr. Pascal BoudjemaCo-founder
DW
Dr. William RassmanCo-founder
JL
Jennifer LeePresident & CEO
WR
William Richard RassmanNamed on SEC filing
PB
Pascal BoudjemaInventor (Dr.)
WR
William RassmanInventor (Dr.)
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2023
▶$1MraisedJun 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedJun 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William Richard RassmanExecutive Officer, Director
- Amount sold
- $1M
- Minimum investment
- $10K
- First sale
- May 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does EnGraft Technologies do?
- Engraft Technologies develops surgical instruments for hair transplant surgery, including the Duplex Implanter, aimed at improving the safety, consistency, and efficiency of the procedure for practitioners. The company operates in the medical device and hair restoration field.
- Who founded EnGraft Technologies?
- EnGraft Technologies was founded by Dr. Pascal Boudjema, Dr. William Rassman in 2023.
- How much funding has EnGraft Technologies raised?
- EnGraft Technologies has disclosed $1M raised across 1 round.
- Where is EnGraft Technologies headquartered?
- EnGraft Technologies is headquartered in Marina Del Rey, US.